Type 2 diabetes mellitus+2
RecruitingA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
- Disease:Type 2 diabetes mellitusObesity+1
- Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
Croatia- Participants:18–64 years · 65+ years
- Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
- Sponsor:Novo Nordisk A/S



